Nanobiotix (NBTX) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Nanobiotix Executive Acquires Significant Share Volume, Signaling Confidence in Future Growth
TipRanksDec 12 12:27 ET
Nanobiotix Updates Share Capital and Voting Rights Information
TipRanksDec 11 16:47 ET
Nanobiotix ADRs Jump on Completed Pancreatic Cancer Treatment Study
WSJDec 10 06:54 ET
Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
BenzingaDec 10 06:05 ET
Nanobiotix's NBTXR3 Clinical Advancements: Promising Outcomes and Strategic Expansion Drive Buy Rating
TipRanksDec 10 04:35 ET · Ratings
Nanobiotix Completes Dose Escalation-expansion Parts of NBTXR3 in PC
TipRanksDec 9 16:26 ET

Comments

8 Seconds

Dec 10 08:37

$Nanobiotix (NBTX.US)$ Nanotix on the volume. Apparently, the market doesn't recognize this ticker. It must be for college frat boys once they get done with class after hours.

Jaguar8

Dec 9 21:04

🟡Watchlist TUESDAY December 10. NFA.

NOTE: There are a lot on my watchlist today which did not yet run. Please do include them in your watchlist up to next week because there are delayed market reactions to news overshadowed by runners.
$Chimerix (CMRX.US)$ PR 12/9 after hours To Submit Dordaviprone For Accelerated Approval To U.S. FDA For Patients With Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End. Ran 100%+ but this is after hour news with conference call tomorrow at 8:30AM ET. May co...

59

12

7

Jaguar8

Dec 9 15:17

NEWS

$Nanobiotix (NBTX.US)$
NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer
Nanobiotix announced completion of Phase 1 study evaluating RT-activated NBTXR3 in pancreatic cancer patients.
The study showed encouraging results with 23 months median Overall Survivalfrom diagnosis in 22 patients with locally advanced or borderline resectable pancreatic cancer, compared to 19.2 months historical control at MD Anderson.
The treatment was well-tolerated, and inv...

2

Jaguar8

Jun 12 15:17

NEWS

$Nanobiotix (NBTX.US)$
NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
NANOBIOTIX (NASDAQ: NBTX), a late-clinical stage biotech company, will host a virtual KOL event on June 18, 2024, from 9:00-10:30AM EDT / 3:00-4:30PM CEST. The event will feature experts including Dr Colette Shen, Dr Ari Rosenberg, and Dr Jeffrey Bockman, who will discuss the company's lead product, NBTXR3. This product, whe...

1

NBTX Nanobiotix

Trade Overview

Capital Trend

News

Comments